2% PTP beat despite higher-than-expected restructuring costs Higher costs are of a one-off nature – ...
Obducat AB (publ) (”Obducat” eller ”Bolaget”) har under årets första kvartal fortsatt vunnit affärer...
ADDvise, som förvärvar bolag inom hälso- och sjukvård, har fått en flygande start på 2023.
En strategisk översyn av planerade kliniska prövningar har inletts.
Redeye states its view of Bredband2’s Q1 2023 report, released earlier today.
Sales and EBIT -1% and +4% vs. ABGSCe Customer intake -2,500 q-o-q (ABGSCe -1,000) Expect relatively...
Fortsatt utmanande marknad i Norden och aktien är pressad.
Redeye provides a first comment on Infracom’s Q1 2023 report, released earlier today.
Sales SEK 19.2m, -7% vs. ABGSCe SEK 20.6m EBITDA SEK -0.
Enersense’s Q1 results showed extended high growth as well as stabilizing bottom line after last yea...
Episurf Medical’s Q1 sales were broadly in line with our estimate, while operating expenses were sli...
NoHo Partners reported Q1 EBIT of EUR 5.9m, +36% versus Refinitiv consensus and +47% versus our esti...
Vow released its Q1 2023 trading update this morning (as a reminder, the company reports semi-annual...
Redeye provides a preview ahead of Embracer Group’s Q4 2022/2023e report, due on 24th of May.
Redeye updates on Invisio following the company’s Q1-results which came in much stronger than expect...
Redeye returns with an update following the Q1 report.
Net sales at SEK 75.2m, above ABGSCe SEK 70.7m Circular Energy sales shine once again.
2023e sales and EBIT lowered by 1% due to phasing of orders Strong order intake; Sales growth booste...
Q1 report on Thursday, 11 May Öyfjellet finally completed The share is trading at 9x P/E on '23e Q1...
Både omsättning och orderingång ökar kraftigt Omsättningen ökade med 100% under Q1 jämfört med föreg...
